These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 2067339)

  • 1. [Quantitative characteristic of circulating immune complexes in patients with lupus erythematosus and central nervous system disorders].
    Ivanova MM; Sykulev IuK; Blizniuk OI; Tumanova IA
    Klin Med (Mosk); 1991 Mar; 69(3):58-60. PubMed ID: 2067339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of circulating immune complex assay in patients with systemic lupus erythematosus.
    Phi NC; Chien DK; Chinh DV; Péter G
    Acta Med Hung; 1989; 46(2-3):109-20. PubMed ID: 2812955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Central nervous system manifestations in patients with systemic lupus erythematosus. Review of pathogenetic aspects].
    Wollina U
    Psychiatr Neurol Med Psychol (Leipz); 1984 May; 36(5):303-6. PubMed ID: 6484056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A close temporal relationship of liver disease to antiribosomal P0 protein antibodies and central nervous system disease in patients with systemic lupus erythematosus.
    Yoshio T; Masuyama JI; Minota S; Kaneko N; Iwamoto M; Okazaki H; Mimori A; Takeda A; Kano S
    J Rheumatol; 1998 Apr; 25(4):681-8. PubMed ID: 9558169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences among immune complexes: association of C1q in SLE immune complexes with renal disease.
    Greisman SG; Redecha PB; Kimberly RP; Christian CL
    J Immunol; 1987 Feb; 138(3):739-45. PubMed ID: 3492531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Atherogenic cholesterol-containing circulating immune complexes--one of the components of the serum in patients with systemic lupus erythematosus].
    Gerasimova EV; Alekberova ZS; Popkova TV; Sobenin IA
    Klin Med (Mosk); 2003; 81(9):39-41. PubMed ID: 14598590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunochemical determination of DNA in immune complexes present in the circulation of patients with systemic lupus erythematosus.
    Nezlin R; Alarcón-Segovia D; Shoenfeld Y
    J Autoimmun; 1998 Oct; 11(5):489-93. PubMed ID: 9802934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The clinico-immunological characteristics of central nervous system involvement in systemic lupus erythematosus: the relationship with antibodies to cardiolipin].
    Travkina IV; Ivanova MM; Nasonov EL; Shmidt TE; Kovalev VIu
    Ter Arkh; 1992; 64(5):10-4. PubMed ID: 1455360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic lupus erythematosus of the central nervous system: 2. Molecular theories and models for mental disease.
    Moskowitz N
    Mt Sinai J Med; 1989 Jan; 56(1):23-9. PubMed ID: 2784179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurement of circulating immune complexes containing IgG, IgM, IgA and IgE by flow cytometry: correlation with disease activity in patients with systemic lupus erythematosus.
    Kingsmore SF; Thompson JM; Crockard AD; Todd D; McKirgan J; Patterson C; Fay AC; McNeill TA
    J Clin Lab Immunol; 1989 Sep; 30(1):45-52. PubMed ID: 2534927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential roles of the anti-ribosomal P antibody and antineuronal antibody in the pathogenesis of central nervous system involvement in systemic lupus erythematosus.
    Isshi K; Hirohata S
    Arthritis Rheum; 1998 Oct; 41(10):1819-27. PubMed ID: 9778223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low serum antimycobacterial glycolipid antibody titers in the sera of patients with systemic lupus erythematosus associated with central nervous system involvement.
    Teplizki H; Buskila D; Argov S; Isenberg D; Coates AR; Sukenik S; Horowitz J; Shoenfeld Y
    J Rheumatol; 1987 Jun; 14(3):507-11. PubMed ID: 3114486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune complex-like activity associated with abnormal serum lipoproteins in systemic erythematosus.
    Smith GW; Hannan SF; Scott PJ; Simpson IJ
    Clin Exp Immunol; 1982 Apr; 48(1):8-16. PubMed ID: 6979451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced complement-mediated immune complex solubilizing capacity and the presence of incompletely solubilized immune complexes in SLE sera.
    Baatrup G; Petersen I; Jensenius JC; Svehag SE
    Clin Exp Immunol; 1983 Nov; 54(2):439-47. PubMed ID: 6652967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased intrathecal immunoglobulin synthesis of both kappa and lambda types in patients with systemic lupus erythematosus and central nervous system involvement.
    Hirohata S; Miyamoto T
    J Rheumatol; 1986 Aug; 13(4):715-21. PubMed ID: 3095548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Systemic lupus erythematosus accompanied by cutaneous vasculitis. Comparison of molecular size of circulating immune complexes].
    Saito K; Shimojo N; Hoshioka A; Kohno Y; Niimi H; Nakajima H; Tanabe E; Koyama A
    Arerugi; 1990 Mar; 39(3):348-53. PubMed ID: 2375686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating immune complexes in Sjögren's syndrome.
    Ichikawa Y; Takaya M; Arimori S
    Tokai J Exp Clin Med; 1980 Oct; 5(4):367-74. PubMed ID: 6166090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating immune complexes in systemic lupus erythematosus: a reappraisal of the solid phase C1q radioimmunoassay.
    Woodroffe AJ; Nozza JM; Muller KD; McIntosh SL; Hale GM; Clarkson AR
    J Clin Lab Immunol; 1988 May; 26(1):5-7. PubMed ID: 3263507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrathecal levels of matrix metalloproteinases in systemic lupus erythematosus with central nervous system engagement.
    Trysberg E; Blennow K; Zachrisson O; Tarkowski A
    Arthritis Res Ther; 2004; 6(6):R551-6. PubMed ID: 15535833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diminished ability of erythrocytes from patients with systemic lupus erythematosus to limit opsonized immune complex deposition on leukocytes and activation of granulocytes.
    Nielsen CH; Rasmussen JM; Voss A; Junker P; Leslie RG
    Arthritis Rheum; 1998 Apr; 41(4):613-22. PubMed ID: 9550470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.